Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Annette Hastie (Winston-Salem, United States of America), Annette Hastie, Fernando Martinez, Jeff Curtis, Claire Doerschuk, Nadia Hansel, Stephanie Christenson, Nirupama Putcha, Victor Ortega, R. Graham Barr, Betsy Carretta, David Couper, Eric Hoffman, Richard Kanner, Eric Kleerup, Neil Alexis, Prescott Woodruff, MeiLan Han, Deborah Meyers, Eugene Bleecker
Source: International Congress 2016 – What's new in biomarker analysis?
Session: What's new in biomarker analysis?
Session type: Thematic Poster
Number: 909
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Annette Hastie (Winston-Salem, United States of America), Annette Hastie, Fernando Martinez, Jeff Curtis, Claire Doerschuk, Nadia Hansel, Stephanie Christenson, Nirupama Putcha, Victor Ortega, R. Graham Barr, Betsy Carretta, David Couper, Eric Hoffman, Richard Kanner, Eric Kleerup, Neil Alexis, Prescott Woodruff, MeiLan Han, Deborah Meyers, Eugene Bleecker. Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia. Eur Respir J 2016; 48: Suppl. 60, 909
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: